1.Kuralay E, Demirkilic U, Oz BS, Cingoz F, Tatar H: Primary pulmonary hypertension and coronary artery bypass surgery. J Card Surg 2002, 17(1):79-80.
2.Reich DL, Bodian CA, Krol M, Kuroda M, Osinski T, Thys DM: Intraoperative hemodynamic predictors of mortality, stroke, and myocardial infarction after coronary artery bypass surgery. Anesth Analg 1999, 89(4):814-822.
3.Pritts CD, Pearl RG: Anesthesia for patients with pulmonary hypertension. Curr Opin Anaesthesiol 2010, 23(3):411-416.
4.Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, Davila-Roman VG, Gerhard-Herman MD, Holly TA, Kane GC et al: 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 2014, 64(22):e77-137.
5.Poms AD, Turner M, Farber HW, Meltzer LA, McGoon MD: Comorbid conditions and outcomes in patients with pulmonary arterial hypertension: a REVEAL registry analysis. Chest 2013, 144(1):169-176.
6.Ramakrishna G, Sprung J, Ravi BS, Chandrasekaran K, McGoon MD: Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality. J Am Coll Cardiol 2005, 45(10):1691-1699.
7.Snopek G, Pogorzelska H, Zielinski T, Rajecka A, Korewicki J, Biederman A, Kotlinski Z: Valve replacement for aortic stenosis with severe congestive heart failure and pulmonary hypertension. J Heart Valve Dis 1996, 5(3):268-272.
8.Sundaresan S: The impact of bronchiolitis obliterans on late morbidity and mortality after single and bilateral lung transplantation for pulmonary hypertension. Semin Thorac Cardiovasc Surg 1998, 10(2):152-159.
9.Pasaoglu I, Demircin M, Dogan R, Ozmen F, Ersoy U, Boke E, Bozer AY: Mitral valve surgery in the presence of pulmonary hypertension. Jpn Heart J 1992, 33(2):179-184.
10.McCurry KR, Keenan RJ: Controlling perioperative morbidity and mortality after lung transplantation for pulmonary hypertension. Semin Thorac Cardiovasc Surg 1998, 10(2):139-143.
11.Meyer S, McLaughlin VV, Seyfarth HJ, Bull TM, Vizza CD, Gomberg-Maitland M, Preston IR, Barbera JA, Hassoun PM, Halank M et al: Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey. Eur Respir J 2013, 41(6):1302-1307.
12.Tedford RJ, Hassoun PM, Mathai SC, Girgis RE, Russell SD, Thiemann DR, Cingolani OH, Mudd JO, Borlaug BA, Redfield MM et al: Pulmonary capillary wedge pressure augments right ventricular pulsatile loading. Circulation 2012, 125(2):289-297.
13.Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF et al: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013, 62(25 Suppl):D34-41.
14.Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, Gaine S: Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004, 43(12 Suppl S):40S-47S.
15.Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS et al: Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J 2009, 30(20):2493-2537.
16.Herasevich V, Kor DJ, Li M, Pickering BW: ICU data mart: a non-iT approach. A team of clinicians, researchers and informatics personnel at the Mayo Clinic have taken a homegrown approach to building an ICU data mart. Healthc Inform 2011, 28(11):42, 44-45.
17.Cavalcante AN, Sprung J, Schroeder DR, Weingarten TN: Multimodal Analgesic Therapy With Gabapentin and Its Association With Postoperative Respiratory Depression. Anesth Analg 2017, 125(1):141-146.
18.Charlson M, Szatrowski TP, Peterson J, Gold J: Validation of a combined comorbidity index. J Clin Epidemiol 1994, 47(11):1245-1251.
19.Hartmann F, Packer M, Coats AJ, Fowler MB, Krum H, Mohacsi P, Rouleau JL, Tendera M, Castaigne A, Anker SD et al: Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe chronic congestive heart failure: a substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) trial. Circulation 2004, 110(13):1780-1786.
20.Srisawasdi P, Vanavanan S, Charoenpanichkit C, Kroll MH: The effect of renal dysfunction on BNP, NT-proBNP, and their ratio. Am J Clin Pathol 2010, 133(1):14-23.
21.Schmid E, Hilberath JN, Blumenstock G, Shekar PS, Kling S, Shernan SK, Rosenberger P, Nowak-Machen M: Tricuspid annular plane systolic excursion (TAPSE) predicts poor outcome in patients undergoing acute pulmonary embolectomy. Heart Lung Vessel 2015, 7(2):151-158.
22.Forfia PR, Fisher MR, Mathai SC, Housten-Harris T, Hemnes AR, Borlaug BA, Chamera E, Corretti MC, Champion HC, Abraham TP et al: Tricuspid annular displacement predicts survival in pulmonary hypertension. Am J Respir Crit Care Med 2006, 174(9):1034-1041.
23.Fine NM, Chen L, Bastiansen PM, Frantz RP, Pellikka PA, Oh JK, Kane GC: Reference Values for Right Ventricular Strain in Patients without Cardiopulmonary Disease: A Prospective Evaluation and Meta-Analysis. Echocardiography 2015, 32(5):787-796.
24.Sachdev A, Villarraga HR, Frantz RP, McGoon MD, Hsiao JF, Maalouf JF, Ammash NM, McCully RB, Miller FA, Pellikka PA et al: Right ventricular strain for prediction of survival in patients with pulmonary arterial hypertension. Chest 2011, 139(6):1299-1309.
25.Makris K, Spanou L: Acute Kidney Injury: Definition, Pathophysiology and Clinical Phenotypes. Clin Biochem Rev 2016, 37(2):85-98.
26.A language and environment for statistical computing. R Foundation for Statistical Computing [http://www.r-project.org.]
27.Minai OA, Venkateshiah SB, Arroliga AC: Surgical intervention in patients with moderate to severe pulmonary arterial hypertension. Conn Med 2006, 70(4):239-243.
28.Price LC, Montani D, Jais X, Dick JR, Simonneau G, Sitbon O, Mercier FJ, Humbert M: Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension. Eur Respir J 2010, 35(6):1294-1302.
29.Martinez-Rumayor A, Richards AM, Burnett JC, Januzzi JL, Jr.: Biology of the natriuretic peptides. Am J Cardiol 2008, 101(3A):3-8.
30.Raymond RJ, Hinderliter AL, Willis PW, Ralph D, Caldwell EJ, Williams W, Ettinger NA, Hill NS, Summer WR, de Boisblanc B et al: Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002, 39(7):1214-1219.
31.Miyamoto S, Nagaya N, Satoh T, Kyotani S, Sakamaki F, Fujita M, Nakanishi N, Miyatake K: Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000, 161(2 Pt 1):487-492.
32.Kaw R, Pasupuleti V, Deshpande A, Hamieh T, Walker E, Minai OA: Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery. Respir Med 2011, 105(4):619-624.